-
YTD
-3,5 %
-
1M
-6,66 %
-
3M
-6,19 %
-
6M
4,95 %
-
1Y
46,2 %
-
3Y
-11,72 %
-
5Y
-
-
10Y
-
За ціною біржі з урахуванням виплат доходу
The Global X Genomics & Biotechnology UCITS ETF seeks to replicate as close as possible the performance of the Solactive Genomics v2 Index investing in companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology.
The Global X Genomics & Biotechnology UCITS ETF (USD) (Acc) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in Global. The Mirae Asset Global Investments fund’s base currency is USD and the share class was registered 02.11.2021 with unique ISIN - IE00BM8R0N95. Main exchange is London S.E. (USD) and ticker symbol is GNOM. The total expense ratio is 0.5%. The Global X Genomics & Biotechnology UCITS ETF (USD) (Acc) pays dividends 0 time(s) per year.